OncoAlvo.: Technological Innovation Optimised for the Personalisation of Oncology Therapy (Q2866833): Difference between revisions
Jump to navigation
Jump to search
(BatchIngestion) |
(Added qualifier: readability score (P590521): 0.000011549073841409742) |
||||||
Property / summary: None (English) / qualifier | |||||||
readability score: 0.000011549073841409742
|
Latest revision as of 13:27, 22 March 2024
Project Q2866833 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | OncoAlvo.: Technological Innovation Optimised for the Personalisation of Oncology Therapy |
Project Q2866833 in Portugal |
Statements
258,908.66 Euro
0 references
346,724.18 Euro
0 references
74.67 percent
0 references
3 January 2016
0 references
3 January 2018
0 references
HEARTGENETICS GENETICS AND BIOTECHNOLOGY, S.A.
0 references
Cantanhede
0 references
23 May 2023
0 references
Identifiers
CENTRO-01-0247-FEDER-010500
0 references